November 11, 2024
TOPLINE: A financial navigation (FN) intervention significantly improved financial toxicity scores among patients with cancer, with mean scores increasing from 6.4 to 13.3. The intervention was […]
November 11, 2024
Mental health, family planning, and career aspirations are among the unique challenges faced by younger adults diagnosed with colorectal cancer (CRC) — issues that may not […]
November 11, 2024
More than one third of patients with cancer visited an emergency department (ED) in the 90 days before their diagnosis, according to a study of medical […]
November 11, 2024
A patient has cancer. It’s decision time. Clinician and patient alike face, really, the ultimate challenge when making those decisions. They have to consider the patient’s […]
November 8, 2024
The US Food and Drug Administration (FDA) has approved obecabtagene autoleucel, or obe-cel (AUTO1, Autolus Therapeutics) for the treatment of relapsed or refractory adult B-cell acute […]
November 8, 2024
The US Food and Drug Administration (FDA) sometimes allows cancer drugs with accelerated approvals to remain on the market after confirmatory trials fail. The FDA’s Richard […]
November 8, 2024
TOPLINE: Higher plasma levels of omega-6 and omega-3 fatty acids are associated with a lower incidence of cancer. However, omega-3 fatty acids are linked to an […]
November 8, 2024
TOPLINE: Venetoclax–obinutuzumab combination therapy for untreated chronic lymphocytic leukemia (CLL) shows a 6-year progression-free survival (PFS) rate of 53%. The time-to-next-treatment (TTNT) rate is 65%, with […]
November 7, 2024
TOPLINE: Patients treated for prostate cancer had higher rates of complications, including urinary and sexual issues, than a control group of men. Radiotherapy increases the risk […]